within Pharmacolibrary.Drugs.ATC.N;

model N01BA53
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.011666666666666665,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N01BA53</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tetracaine is a potent local anesthetic of the ester type, commonly used in combination with other substances for topical anesthesia (e.g., ocular, mucosal) due to its rapid onset and intermediate duration of action. Its use is primarily in topical procedures, especially in ophthalmology and minor surgical interventions. It is not commonly used for systemic anesthesia due to toxicity concerns and has largely been replaced by safer alternatives, but still finds approved clinical use as a topical anesthetic.</p><h4>Pharmacokinetics</h4><p>No population pharmacokinetic models or referenced pharmacokinetic parameters are available in the literature specifically for tetracaine combinations assigned to ATC N01BA53. Below parameters are estimated based on available data for tetracaine topical use in healthy adults.</p><h4>References</h4><ol><li><p>Terndrup, TE, et al., &amp; Karatay, CM (1991). Plasma cocaine and tetracaine levels following application of topical anesthesia in a swine laceration model. <i>The American journal of emergency medicine</i> 9(6) 539–543. DOI:<a href=&quot;https://doi.org/10.1016/0735-6757(91)90107-u&quot;>10.1016/0735-6757(91)90107-u</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1930392/&quot;>https://pubmed.ncbi.nlm.nih.gov/1930392</a></p></li><li><p>Fang, C, et al., &amp; Chen, HZ (2008). Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 68(3) 735–740. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2007.02.007&quot;>10.1016/j.ejpb.2007.02.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17398083/&quot;>https://pubmed.ncbi.nlm.nih.gov/17398083</a></p></li><li><p>Russell, SC, &amp; Doyle, E (1997). A risk-benefit assessment of topical percutaneous local anaesthetics in children. <i>Drug safety</i> 16(4) 279–287. DOI:<a href=&quot;https://doi.org/10.2165/00002018-199716040-00005&quot;>10.2165/00002018-199716040-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9113495/&quot;>https://pubmed.ncbi.nlm.nih.gov/9113495</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N01BA53;
